469 related articles for article (PubMed ID: 31757313)
1. Precision Medicine and Targeted Therapies in Breast Cancer.
Greenwalt I; Zaza N; Das S; Li BD
Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
[TBL] [Abstract][Full Text] [Related]
2. Precision Medicine in Pediatric Oncology.
Vo KT; Parsons DW; Seibel NL
Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
[TBL] [Abstract][Full Text] [Related]
3. Precision Medicine.
Khatri VP; Petrelli NJ
Surg Oncol Clin N Am; 2020 Jan; 29(1):xv-xvi. PubMed ID: 31757318
[No Abstract] [Full Text] [Related]
4. Personalized Medicine in Gynecologic Cancer: Fact or Fiction?
Corey L; Valente A; Wade K
Surg Oncol Clin N Am; 2020 Jan; 29(1):105-113. PubMed ID: 31757307
[TBL] [Abstract][Full Text] [Related]
5. Precision Medicine in Lung Cancer Treatment.
Shah DR; Masters GA
Surg Oncol Clin N Am; 2020 Jan; 29(1):15-21. PubMed ID: 31757310
[TBL] [Abstract][Full Text] [Related]
6. Oral Cancer: Genetics and the Role of Precision Medicine.
Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
Surg Oncol Clin N Am; 2020 Jan; 29(1):127-144. PubMed ID: 31757309
[TBL] [Abstract][Full Text] [Related]
7. Individualizing Care: Management Beyond Medical Therapy.
Cristoferi L; Nardi A; Invernizzi P; Mells G; Carbone M
Surg Oncol Clin N Am; 2020 Jan; 29(1):87-103. PubMed ID: 31757316
[TBL] [Abstract][Full Text] [Related]
8. Precision Medicine in the Treatment of Melanoma.
Aderhold K; Wilson M; Berger AC; Levi S; Bennett J
Surg Oncol Clin N Am; 2020 Jan; 29(1):1-13. PubMed ID: 31757306
[TBL] [Abstract][Full Text] [Related]
9. Genomics and the History of Precision Oncology.
Doroshow DB; Doroshow JH
Surg Oncol Clin N Am; 2020 Jan; 29(1):35-49. PubMed ID: 31757312
[TBL] [Abstract][Full Text] [Related]
10. Is precision medicine ready for use in breast cancer?
Pusztai L
Clin Adv Hematol Oncol; 2016 Dec; 14(12):964-966. PubMed ID: 28212357
[No Abstract] [Full Text] [Related]
11. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
Crombie JL; Armand P
Surg Oncol Clin N Am; 2020 Jan; 29(1):115-125. PubMed ID: 31757308
[TBL] [Abstract][Full Text] [Related]
12. Evolution of Targeted Therapy in Breast Cancer: Where Precision Medicine Began.
Meisel JL; Venur VA; Gnant M; Carey L
Am Soc Clin Oncol Educ Book; 2018 May; 38():78-86. PubMed ID: 30231395
[TBL] [Abstract][Full Text] [Related]
13. Successes and limitations of targeted cancer therapy in breast cancer.
Curigliano G; Criscitiello C
Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
[TBL] [Abstract][Full Text] [Related]
14. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
15. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
16. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
17. Proteomic advances hold promise for precision medicine.
Smith AD
Am J Manag Care; 2014 Mar; 20(5 Spec No.):E14. PubMed ID: 25618628
[No Abstract] [Full Text] [Related]
18. Paul Workman: Drugging the Cancer Genome.
Trends Cancer; 2016 Oct; 2(10):544-548. PubMed ID: 27904887
[No Abstract] [Full Text] [Related]
19. New ESMO scale ranks mutations as cancer medicine targets.
Fricker J
Lancet Oncol; 2018 Oct; 19(10):e513. PubMed ID: 30177495
[No Abstract] [Full Text] [Related]
20. Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.
Meric-Bernstam F; Johnson AM; Dumbrava EEI; Raghav K; Balaji K; Bhatt M; Murthy RK; Rodon J; Piha-Paul SA
Clin Cancer Res; 2019 Apr; 25(7):2033-2041. PubMed ID: 30442682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]